Candida: A causative agent of an emerging infection

Journal of Investigative Dermatology Symposium Proceedings

Volumn 6, Issue 3, 2001, Pages 188-196

  Ghannoum, Mahmoud A ^a,b  

^a UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Antifungals management; Diagnosis; Susceptibility

Indexed keywords

ANTIFUNGAL AGENT;

CANDIDIASIS; HUMAN; REVIEW;

ANTIFUNGAL AGENTS; CANDIDIASIS; HUMANS;

EID: 0035749865     PISSN: 10870024     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.0022-202x.2001.00047.x     Document Type: Article

References (31)

1. Angel JD, Kuman A, Parato K, et al: Improvement in cell-mediated immune functions during potent anti-human immunodeficiency virus therapy with ritonavir plus saquinavir. J Infect Dis 177:898-904, 1998
2. Autran B, Carcelain G, Li TS, et al: Positive effects of combined antiretroviral therapy on CD4 T cell homeostasis and function in advanced HIV disease. Science 277:112-116, 1997
3. Barchiesi F, Arzeni D, Fothergill AW, et al: In vitro activities of the new antifungal triazole SCH 56592 against common and emerging yeast pathogens. Antimicrob Agents Chemother 44:226-229, 2000
4. Barchiesi F, Hollis RJ, McGough DA, Scalise G, Rinaldi MG, Pfaller MA: DNA subtypes and fluconazole susceptibilities of Candida albicans isolates from the oral cavities of patients with AIDS. Clin Infect Dis 20:634-640, 1995
5. Bart-Delabesse E, Boiron P, Carlotti A, Dupont B: Candida albicans genotyping in studies with patients with AIDS developing resistance to fluconazole. J Clin .Microbiol 31:2933-2937, 1993
6. Bartizal K, Gill CJ, Abruzzo GK, et al: In vitro preclinical evaluation studies with the echinocandin antifungal MK-0991 (L-743,872). Antimicrob Agents Chemother 41:2326-2332, 1997
7. Belanger P, Nast CC, Fratti R, Sanati H, Ghannoum M: Voriconazole (UK-109,496) inhibits the growth and alters the morphology of fluconazolesusceptible and - resistant Candida species. Antimicrob Agents Chemother 41:1840-1842, 1997
8. Bennett JE: Rapid diagnosis of candidiasis and aspergillosis. Rev Infect Dis 9:398-402, 1987
9. Bougnoux ME, Hill C, Moissenet D, et al Comparison of antibody, antigen, and metabolite assays for hospitalized patients with disseminated or peripheral candidiasis. J Clin Microbiol 28:905-909, 1990
10. Brajtburg J, Bolard J: Carrier effects on biological activity of amphotericin B. Clin Microbiol Rev 9:512-531, 1996
11. Buchman T, Rossier M, Merz WG, Charache P: Detection of surgical pathogens by in vitro DNA amplification. Part I. Rapid identification of Candida albicans by in vitro amplification of a fungus-specific gene. Surgery 108:338-346, 1990
12. Cassone A, DeBernardis F, Torosantucci A, Tacconelli E, Tumbarello M, Cauda R: In vitro and in vivo anticandidal activity of human immunodeficiency virus protease inhibitors. J Infect Dis 180:448-453, 1999
13. Chen YC, Chang SC, Sun CC, Yang LS, Hsieh WC, Luh KT: Secular trends in the epidemiology of nosocomial fungal infections at a teaching hospital in Taiwan, 1981-93. Infect Control Hasp Epidemiol 18:369-375, 1997
14. Christensson B, Wiebe T, Pehrson C, Larsson L: Diagnosis of invasive candidiasis in neutropenic children with cancer by determination of D-arabinitol/L-arabinitol ratios in urine. J Clin Microbiol 35:636-640, 1997
15. Cleary JD, Hayman J, Sherwood J, Lasala GP, Piazza-Hepp T: Amphotericin B overdose in pediatric patients with associated cardiac arrest. Ann Phanuacother 27:715-719, 1993
16. Connolly P, Wheat J, Schnizlein-Bick C, et al: Comparison of a new triazole antifungal agent, Schering 56592, with itraconazole and amphotericin B for treatment of histoplasmosis in immunocompetent mice. Antimicrob Agents Chemother 43:322-328, 1999
17. Debono M, Gordee RS: Antibiotics that inhibit fungal cell wall development. Annu Rev Microbiol 48:471-497, 1994
18. Defontaine A, Bouchara JP, Declerk P, Planchenault C, Chabasse D, Hallet JN: Invitro resistance to azoles associated with mitochondrial DNA deficiency in Candida glabrata. J Med Microbiol 48:663-670, 1999
19. van Deventer AJ, Goessens WH, van Zeijl JH, Mouton JW, Michel MF, Verbrugh HA: Kinetics of anti-mannan antibodies useful in confirming invasive candidiasis in immunocompromised patients. .Microbiol Immunol 40:125-131, 1996
20. Diasio RB, Bennett JE, Myers CE: Mode of action of 5-fluorocytosine. Biochem Pharmacol 27:703-707, 1978
21. de Doncker P. van Lint J, Docks P, Roseeuw D: Pulse therapy with one-week itraconazole monthly for three or four months in the treatment of onychomycosis. Cutis 56:180-183, 1995
22. Edmond MB, Wallace SE, McClish DK, Pfaller MA, Jones RN, Wenzel RP: Nosocomial bloodstream infections in United States hospitals: a three-year analysis. Clin Infect Dis 29:239-244, 1999
23. Edwards JE Jr, Bodey GP, Bowden RA, ct al International Conference for the Development of a Consensus on the Management and Prevention of Severe Candidal Infections. Clin Infect Dis 25:43-59, 1997
24. Espinel-IngrofFA, Kerkering TM, Goldson PR, Shadomy S: Comparison study of broth macrodilution and microdilution antifungal susceptibility tests. J Clin Microbiol 29:1089-1094, 1991
25. Espinel-Ingroff A, Kish CW, Kerkering TM, et al: Collaborative comparison of broth macrodilution and microdilution antifungal susceptibility tests. J Clin Microbiol 30:3138-3145, 1992
26. Fisher-Hoch SP, Hutwagner L: Opportunistic Candidiasis. An epidemic of the 1980s. Clin Infect Dis 21:897-904, 1995
27. Flahaut M, Sanglard D, Monod M, Bille J, Rossier M: Rapid detection of Candida albicans in clinical samples by DNA amplification of common regions from C. albicans-secreted aspartic proteinase genes. J Clin Microbiol 36:395-401, 1998
28. Fratti RA, Belanger P, Sanati H, Ghannoum MA: The effect of the new triazole, voriconazole (UK-109,496), on the interactions of Candida albicans and Candida krusei with endothelial cells. J Chemother 10:7-16, 1998
29. Fromtling RA, Galgiani JN, Pfaller MA, et al: Multicenter evaluation of a macrobroth antifungal susceptibility test for yeasts. Antimicrob Agents Chemother 37:39-45, 1993
30. Fujita S, Hashimoto T: Detection of serum Candida antigens by enzyme-linked immunosorbent assay and a latex agglutination test with anti-Candida albicans and anti-Candida krusei antibodies. J Clin Microbiol 30:3132-3137, 1992
31. Fung-Tomc JC, Huczko E, Minassian B, Bonner DP: In vitro activity of a new oral triazole, BMS-207147 (ER-30346). Antimicrob Agents Chemother 42:313-318, 1998